From January 22, 2024 to March 31, 2024, the company has repurchased 1,150,000 shares, representing 0.86% for CNY 62.43 million. With this, the company has completed the repurchase of 1,150,000 shares, representing 0.86% for CNY 62.43 million under the buyback announced on January 23, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62.81 CNY | +1.90% | +0.66% | -19.00% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.00% | 1.15B | |
-3.15% | 89.69B | |
+3.95% | 41.34B | |
-10.51% | 33.72B | |
+60.52% | 26.11B | |
-20.09% | 14.63B | |
-8.92% | 12.84B | |
-11.46% | 11.66B | |
-43.05% | 11.52B | |
+4.04% | 8.92B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on January 23, 2024.